SK Capital agrees to acquire business from Catalent Pharma Solutions

The unit will operate as a newly independent company once the deal closes, which is expected in April 2021.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this